Arfolitixorin |
ISO-901; 6R-MTHF |
Phase 3 Clinical |
Isofol Medical Ab |
Rectal Neoplasms; Colonic Neoplasms; Osteosarcoma; Colorectal Neoplasms |
Details
|
Luveltamab tazevibulin |
STRO-002 |
Phase 3 Clinical |
Sutro Biopharma Inc |
Solid tumours; Ovarian Neoplasms; Carcinoma, Ovarian Epithelial; Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Endometrial Neoplasms; Carcinoma, Endometrioid |
Details
|
CBP-1008 |
CBP-1008 |
Phase 2 Clinical |
|
Solid tumours; Ovarian Neoplasms; Carcinoma, Ovarian Epithelial; Breast Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Squamous Cell |
Details
|
Farletuzumab |
MORAb-003 |
Phase 2 Clinical |
Morphotek Inc |
Ovarian Neoplasms; Solid tumours; Neoplasms; Carcinoma, Ovarian Epithelial; Adenocarcinoma of Lung; Peritoneal Neoplasms; Fallopian Tube Neoplasms |
Details
|
Rinatabart Sesutecan |
PRO-1184 |
Phase 2 Clinical |
ProfoundBio (Suzhou) Co Ltd |
Solid tumours; Ovarian Neoplasms; Triple Negative Breast Neoplasms; Mesothelioma; Breast Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
ELU-001 |
ELU-001 |
Phase 2 Clinical |
Elucida Oncology Inc |
Ovarian Neoplasms; Uterine Diseases; Carcinoma, Ovarian Epithelial; Ovarian Diseases; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Endometrial Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Endometrioid; Neoplasm Metastasis; Adenocarcinoma |
Details
|
AZD5335 |
AZD5335; AZD-5335 |
Phase 2 Clinical |
Astrazeneca Plc |
Ovarian Neoplasms; Solid tumours; Adenocarcinoma of Lung |
Details
|
Farletuzumab ecteribulin |
MORAb-202 |
Phase 2 Clinical |
Morphotek Inc, Bristol-Myers Squibb Company, Eisai Co Ltd |
Ovarian Neoplasms; Solid tumours; Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
BAT-8006 |
BAT8006; BAT-8006 |
Phase 2 Clinical |
Bio-Thera Solutions Ltd |
Solid tumours; Carcinoma, Ovarian Epithelial |
Details
|
4S-CAR-FRa |
4S-CAR-FRa |
Phase 2 Clinical |
Shenzhen Geno-Immune Medical Institute |
Carcinoma, Transitional Cell; Urinary Bladder Neoplasms |
Details
|
Noscapine-folate conjugate |
|
Phase 1 Clinical |
Emory University |
Hematologic Neoplasms; Inflammation |
Details
|
MOv-18 IgE |
MOv-18 IgE; MOv18; MOv-18 |
Phase 1 Clinical |
King'S College London, Cancer Research UK |
Ovarian Neoplasms; Neoplasms |
Details
|
ITIL-306 |
ITIL-306 |
Phase 1 Clinical |
Instil Bio Inc |
Solid tumours; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Genital Neoplasms, Female; Carcinoma, Non-Small-Cell Lung |
Details
|
IMGN-151 |
IMGN-151 |
Phase 1 Clinical |
Immunogen Inc |
Ovarian Neoplasms; Cystadenocarcinoma, Serous; Breast Neoplasms; Peritoneal Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms |
Details
|
AMT-151 |
AMT-151 |
Phase 1 Clinical |
Multitude Therapeutics Inc |
Solid tumours; Ovarian Neoplasms; Adenocarcinoma of Lung; Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Ovarian Epithelial; Mesothelioma; Adenocarcinoma, Clear Cell; Peritoneal Neoplasms; Carcinoma, Pancreatic Ductal; Endometrial Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Endometrioid; Adenocarcinoma |
Details
|
UB-TT170 |
UB-TT170; UB-TT-170; UB_TT170; UB_TT-170 |
Phase 1 Clinical |
Umoja BioPharma Inc |
Osteosarcoma |
Details
|
Arfolitixorin |
ISO-901; 6R-MTHF |
Phase 3 Clinical |
Isofol Medical Ab |
Rectal Neoplasms; Colonic Neoplasms; Osteosarcoma; Colorectal Neoplasms |
Details
|
Luveltamab tazevibulin |
STRO-002 |
Phase 3 Clinical |
Sutro Biopharma Inc |
Solid tumours; Ovarian Neoplasms; Carcinoma, Ovarian Epithelial; Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Endometrial Neoplasms; Carcinoma, Endometrioid |
Details
|
CBP-1008 |
CBP-1008 |
Phase 2 Clinical |
|
Solid tumours; Ovarian Neoplasms; Carcinoma, Ovarian Epithelial; Breast Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Squamous Cell |
Details
|
Farletuzumab |
MORAb-003 |
Phase 2 Clinical |
Morphotek Inc |
Ovarian Neoplasms; Solid tumours; Neoplasms; Carcinoma, Ovarian Epithelial; Adenocarcinoma of Lung; Peritoneal Neoplasms; Fallopian Tube Neoplasms |
Details
|
Rinatabart Sesutecan |
PRO-1184 |
Phase 2 Clinical |
ProfoundBio (Suzhou) Co Ltd |
Solid tumours; Ovarian Neoplasms; Triple Negative Breast Neoplasms; Mesothelioma; Breast Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
ELU-001 |
ELU-001 |
Phase 2 Clinical |
Elucida Oncology Inc |
Ovarian Neoplasms; Uterine Diseases; Carcinoma, Ovarian Epithelial; Ovarian Diseases; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Endometrial Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Endometrioid; Neoplasm Metastasis; Adenocarcinoma |
Details
|
AZD5335 |
AZD5335; AZD-5335 |
Phase 2 Clinical |
Astrazeneca Plc |
Ovarian Neoplasms; Solid tumours; Adenocarcinoma of Lung |
Details
|
Farletuzumab ecteribulin |
MORAb-202 |
Phase 2 Clinical |
Morphotek Inc, Bristol-Myers Squibb Company, Eisai Co Ltd |
Ovarian Neoplasms; Solid tumours; Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
BAT-8006 |
BAT8006; BAT-8006 |
Phase 2 Clinical |
Bio-Thera Solutions Ltd |
Solid tumours; Carcinoma, Ovarian Epithelial |
Details
|
4S-CAR-FRa |
4S-CAR-FRa |
Phase 2 Clinical |
Shenzhen Geno-Immune Medical Institute |
Carcinoma, Transitional Cell; Urinary Bladder Neoplasms |
Details
|
Noscapine-folate conjugate |
|
Phase 1 Clinical |
Emory University |
Hematologic Neoplasms; Inflammation |
Details
|
MOv-18 IgE |
MOv-18 IgE; MOv18; MOv-18 |
Phase 1 Clinical |
King'S College London, Cancer Research UK |
Ovarian Neoplasms; Neoplasms |
Details
|
ITIL-306 |
ITIL-306 |
Phase 1 Clinical |
Instil Bio Inc |
Solid tumours; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Genital Neoplasms, Female; Carcinoma, Non-Small-Cell Lung |
Details
|
IMGN-151 |
IMGN-151 |
Phase 1 Clinical |
Immunogen Inc |
Ovarian Neoplasms; Cystadenocarcinoma, Serous; Breast Neoplasms; Peritoneal Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms |
Details
|
AMT-151 |
AMT-151 |
Phase 1 Clinical |
Multitude Therapeutics Inc |
Solid tumours; Ovarian Neoplasms; Adenocarcinoma of Lung; Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Ovarian Epithelial; Mesothelioma; Adenocarcinoma, Clear Cell; Peritoneal Neoplasms; Carcinoma, Pancreatic Ductal; Endometrial Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Endometrioid; Adenocarcinoma |
Details
|
UB-TT170 |
UB-TT170; UB-TT-170; UB_TT170; UB_TT-170 |
Phase 1 Clinical |
Umoja BioPharma Inc |
Osteosarcoma |
Details
|